Regina M. Graul - 01 Dec 2023 Form 3/A - Amendment Insider Report for Cyclerion Therapeutics, Inc. (CYCN)

Role
President
Signature
/s/ Regina Margaret Graul
Issuer symbol
CYCN
Transactions as of
01 Dec 2023
Net transactions value
$0
Form type
3/A - Amendment
Filing time
07 Dec 2023, 16:05:05 UTC
Date Of Original Report
04 Dec 2023
Next filing
26 Jan 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding CYCN Common Stock 50,303 01 Dec 2023 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This Amendment to Form 3 increases by 303 shares, the total shares of common stock held by Ms. Graul, reflecting her ownership of these additional shares prior to her becoming President of Cyclerion Therapeutics, Inc. on December 1, 2023.
F2 As previously reported, the Reporting Person was granted 50,000 shares of restricted stock on December 1, 2023 pursuant to the Cyclerion Therapeutics, Inc. 2019 Equity Incentive Plan. 10,000 of the shares vested immediately and the remaining 40,000 shares are subject to vesting ratably over a 48-month period, provided that the Reporting Person remains employed by Cyclerion Therapeutics, Inc. on such applicable vesting date, subject to certain exemptions.